|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910784632203321 |
|
|
Titolo |
Handbook of animal models of infection [[electronic resource] ] : experimental models in antimicrobial chemotherapy / / edited by Oto Zak, Merle Sande |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
San Diego, CA, : Academic Press, c1999 |
|
|
|
|
|
|
|
ISBN |
|
1-281-79561-5 |
9786611795610 |
0-08-053355-8 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (1169 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
ZakOto |
SandeMerle A. <1939-2007.> |
|
|
|
|
|
|
|
|
Disciplina |
|
615.329 |
615.5/8 21 |
615.58 |
|
|
|
|
|
|
|
|
Soggetti |
|
Animal models in research |
Infection - Chemotherapy - Animal models - Evaluation |
Communicable diseases - Chemotherapy - Animal models - Evaluation |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Front Cover; Handbook of Animal Models of Infection; Copyright Page; Contents; List of Section Editors; List of Contributors; Preface; Introduction: The Role of Animal Models in the Evaluation of New Antibodies; Section I: INTRODUCTORY BACKGROUND TO ANIMAL MODELS OF INFECTION; Chapter 1. Early History of Animal Models of Infection; Chapter 2. General Methodologies for Animal Models; Chapter 3. Ethics Committees in Europe-An Overview; Chapter 4. Animal Care and Use Committees-An American Perspective; Chapter 5. Ethical Aspects of the Use of Animal Models of Infection |
Chapter 6. The Impact of General Laboratory Animal Health on Experimental Models in Antimicrobial ChemotherapyChapter 7. Non-invasive Monitoring of Infection and Gene Expression in Living Animal Models; Chapter 8. Considerations for Working Safely with Infectious Disease Agents in Research Agents; Chapter 9. Analysis of Genetic Susceptibility to Infection in Mice; Chapter 10. Formulation of |
|
|
|
|